FRAMINGHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has been named the 2024 Databricks Healthcare and Life Sciences Partner of the Year. This prestigious award recognizes Definitive Healthcare's exceptional collaboration with Databricks in delivering innovative data and AI solutions to the healthcare and life sciences industry. “We are incredibly honored to be recognized by Databricks as their H ...

文章核心观点 - 公司发布了2023年可持续发展报告,展示了公司在环境、社会和治理(ESG)实践方面的持续承诺[1][2] - 公司认为可持续发展对于长期成功至关重要,并将继续寻找减少环境影响和回馈社区的方式[2] - 报告重点介绍了公司业务、利益相关方和增长最重要的可持续性主题,包括全球多元化和包容性员工招聘与管理、隐私和数据保护、能源和排放[2] 公司环境方面的进展 - 聘请ESG顾问量化公司温室气体排放,建立未来排放的基准[3] - 关闭了最不节能的办公室[3] 公司社会方面的进展 - 提高了高管层面的女性和种族多样性,技术和非技术员工的种族多样性也有所提高[3] - 被评为2023年波士顿最佳中型公司之一,获得美国顶级工作场所认证,并在印度获得优秀工作场所认证[3] - 贡献了1,940个志愿服务时间,并通过DefinitiveCares计划直接和间接筹集了超过30万美元的慈善捐款[3] 公司治理方面的进展 - 完成了SOC2评估并获得无保留的SOC2 II型认证(最近收购的一个产品线除外),涵盖所有五个信任服务标准[3] - 根据网络安全中心(CIS)控制标准v8和SOC2指南增强了网络安全和数据隐私框架[3]

FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the Stifel 2024 Cross Sector Insight Conference. The Definitive Healthcare presentation is scheduled for Tuesday, June 4, 2024, at 9:10 a.m. Eastern Time. A live webcast of the presentation will be available on the Events page of the ...

Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings e ...

A downtrend has been apparent in Definitive Healthcare Corp. (DH) lately. While the stock has lost 24.3% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support. While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the ...

First quarter 2024 earnings presentation May 7, 2024 Cautionary statement regarding forward-looking statements This presentation includes forward-looking statements that reflect our current views with respect to future events Additional factors or events that could cause our actual performance to differ from these forward-looking and financial performance. Such statements are provided under the “safe harbor” protection of the Private statements may emerge from time to time, and it is not possible for us to ...

财务数据和关键指标变化 - 公司第一季度总收入为6350万美元,同比增长7% [25][26] - 公司第一季度调整后EBITDA为2000万美元,同比增长28%,EBITDA利润率为32% [24][32] - 公司第一季度调整后净收益为1300万美元,同比增长44% [32] - 公司第一季度每股调整后收益为0.08美元,同比增长41% [32] - 公司过去12个月未计息自由现金流为7610万美元,同比增长43% [33] 各条业务线数据和关键指标变化 - 公司第一季度专业服务收入为170万美元 [25] - 公司第一季度毛利率为83.6%,同比下降约60个基点,但剔除Populi影响后毛利率同比扩大超过100个基点 [27] 各个市场数据和关键指标变化 - 公司第一季度企业客户数量为559家,同比增长6% [25][26] - 公司第一季度总客户数约2800家,同比下降约200家,环比下降100家,主要是小客户受到当前经济环境影响 [26] 公司战略和发展方向及行业竞争 - 公司正在进行重组,调整销售团队架构,减少销售人员重叠,并为中小客户设立独立销售团队,以更好地服务不同规模客户 [12][16] - 公司将继续专注于提升运营效率、产品创新和客户成功三大方面 [16][20] - 公司正在扩展数据资产,增加新的医疗机构类型,如输液中心和癌症中心 [17] - 公司正在将其流行的索赔分析和可视化平台扩展到所有终端市场 [17] - 公司正在开发基于人工智能和数据科学的新产品,如DH市场预测工具 [18] - 公司已完成Carevoyance公司的整合,并看到了良好的市场需求 [19] 管理层对经营环境和未来前景的评论 - 宏观经济环境持续给公司带来挑战,销售周期延长,客户更加谨慎 [12] - 公司重组初期造成了一定程度的销售中断,但现已完成过渡 [12][13] - 公司有信心通过提升运营效率和产品创新来推动长期增长 [10][43] - 公司预计2024年全年收入增长1%-4%,调整后EBITDA利润率将保持在32%-33% [38][39] 问答环节重要的提问和回答 问题1 **Craig Hettenbach 提问** 询问公司重组后的销售情况以及对中小客户的策略 [45][49] **Jason Krantz 回答** 公司已完成重组,现正专注于提升销售团队的工作效率和管线建设。对中小客户采取独立的销售策略,以更高效的方式为他们提供服务 [46][49] 问题2 **Jared Haase 提问** 询问公司二季度及全年收入指引的依据 [52][53] **Rick Booth 回答** 公司预计续费率和扩展率将持续改善,同时假设第二半年销售生产率与一季度相当,并考虑了专业服务收入的下降 [53] 问题3 **David Grossman 提问** 询问Populi和Carevoyance并购对公司的影响 [67][72] **Jason Krantz 回答** 公司采取快速整合的策略,将这些公司的产品快速融入自身产品组合,并通过中心化的销售和后台支持来实现协同效应 [72]

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post earnings of $0.07 per share when it actually produced earnings of $0.07, delivering no surprise. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Definitive Healthcare, whic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other jur ...

财务业绩 - 第一季度营收为6,350万美元，同比增长7%[2] - 调整后的净收入为1,300万美元，较去年同期的910万美元增长[2] - 调整后的EBITDA为2,000万美元，占营收的32%[2] - 企业客户数量增长30家，年同比增长6%[4] - 2024年第一季度，Definitive Healthcare Corp.的营收为63480千美元[33] - 2024年第一季度，Definitive Healthcare Corp.的毛利为50382千美元，毛利率为79%[33] - 2024年第一季度，Definitive Healthcare Corp.的调整后毛利为53096千美元，调整后毛利率为84%[37] 财务展望 - 第二季度预计营收将在6,200 - 6,350万美元之间，同比增长2-4%[9] - 全年2024预计营收将在2.55 - 2.61亿美元之间，同比增长1-4%[10] 公司行动 - 公司董事会批准回购总额为2,000万美元的A类普通股[7] - 公司将举行电话会议讨论财务业绩和业务展望[12] 非核心支出 - 非核心法律和监管支出为负865,000美元，较上年同期1,049,000美元下降[40] - 非重复战略重组咨询费用为330,000美元，较上年同期无[40] - 其他非核心支出为7,000美元，较上年同期227,000美元下降[40]